关于“科莱威”的报告
-
艾媒咨询 | 2024-2025年中国化妆品市场运行状况及发展趋势研究报告
在消费结构升级、审美观念和悦己意识增强等多种因素的推动下,国内化妆品消费持续增长。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024-2025年中国化妆品市场运行状况及发展趋势研究报告》数据显示,2023年中国化妆品行业市场规模约为5169.0亿元,同比增长6.4%,2025年有望增至5791.0亿元。近年来,国产化妆品品牌凭借高性价比与渠道精细化运营实现了迅速增长。在消费者对高端国际品牌整体祛魅的趋势下,国货品牌应将产品与营销的转型创新视为企业发展及再增长的关键,以满足市场的需求,提高企业竞争力。
Driven by many factors such as the upgrading of consumption structure, the enhancement of aesthetic concept and self-pleasing consciousness, domestic cosmetics consumption continues to grow. According to the latest "Research Report on the Operation Status and Development Trend of China's Cosmetics Market in 2024-2025" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's cosmetics industry in 2023 is about 516.09 billion yuan, an increase of 6.4%. It is expected to increase to 579.10 billion yuan by 2025. In recent years, domestic cosmetics brands have achieved rapid growth with high cost performance and refined channel operation. Under the trend of consumers' overall disenchantment of high-end international brands, domestic brands should regard the transformation and innovation of products and marketing as the key to the development and re-growth of enterprises, so as to meet the needs of the market and improve the competitiveness of enterprises. -
艾媒咨询|2021年中国口腔医院产业细分领域及总趋势分析报告
本报告研究涉及企业/品牌/案例:Straumann,正畸,时代天使,通策医疗,泰康拜博口腔
2020年受疫情影响,口腔医疗行业整体营收有所下降。在此背景下,全国性口腔连锁扩张势头减缓,可能下沉到3、4线城市。同时,资本在布局口腔行业时将逐渐趋于理性,口腔行业现有经济泡沫会被有效挤出。总体口腔医疗行业集中度低,前五头部机构市占率较低。虽然受疫情影响,行业连锁扩张暂缓,但随着行业的不断发展,连锁口腔机构将继续成为口腔医疗机构发展重点。
In 2020, affected by the epidemic, the overall revenue of the oral medical industry decreased. In this context, the expansion momentum of national oral chain has slowed down and may sink to Tier 3 and 4 cities. At the same time, capital will gradually become rational in the layout of the dental industry, and the existing economic bubble in the dental industry will be effectively squeezed out. The overall concentration of the oral medical industry is low, and the market share of the top five institutions is low. Although the expansion of the industry chain is suspended due to the epidemic situation, with the continuous development of the industry, chain oral institutions will continue to become the focus of the development of oral medical institutions. -
艾媒咨询|2021年9-10月中国化妆品行业运行数据监测双月报:“双十一” 战报
本报告涉及的案例/品牌/企业:C咖,悦瞳,林清轩
数据显示,今年年初社会消费品零售总额受去年低基数的影响,同比高增。自三月以来中国社会消费品零售总额与化妆品类商品零售值同比增长速度总体呈现下滑趋势。艾媒咨询分析师认为,受中国疫情零星出现以及宏观经济景气度等原因,居民总体消费意愿减弱,如将来疫情仍未解决,或一定程度影响化妆品消费的总体需求。不过,从数据来看,今年美妆护肤类产品线上复购需求多于线下体验需求,且对即时性要求不高,在整体电商经济增速下降的环境下,未来美妆护肤类产品线上销售增速仍能够保持高增长趋势。
Data show that at the beginning of this year, the total retail sales of social consumer goods increased year-on-year due to the impact of last year's low base. Since March, the year-on-year growth rate of China's total retail sales of social consumer goods and the retail value of cosmetics has generally shown a downward trend. iiMedia Research analysts believe that due to the sporadic occurrence of the epidemic in China and the macroeconomic boom, the overall consumption willingness of residents is weakened. If the epidemic has not been solved in the future, it may affect the overall demand for cosmetics consumption to a certain extent. However, from the data, this year, the demand for online re purchase of beauty and skin care products is more than the demand for offline experience, and the requirement for timeliness is not high. Under the environment of declining overall e-commerce economic growth, the growth rate of online sales of beauty and skin care products can still maintain a high growth trend in the future. -
艾媒咨询|2021年7-8月中国化妆品行业运行数据监测双月报
本报告研究涉及企业/品牌/案例:贝泰妮,珀莱雅,丸美股份
数据显示,2021年8月阿里平台护肤及化妆品类GMV为199.1亿元,同比下降5.0%,其中护肤类GMV140.0 亿元,同比下降0.8%,彩妆类GMV59.2亿元,同比下降13.6%。双十一电商购物节成交额近五年平均增长率为32.5%,购物气氛活跃。2020年双十一电商购物节全网个护美妆品类销售额909亿元,同比增长43%。其中,护肤销售额达 755 亿元,同比增长 45%;美妆彩妆销售额为 154 亿元,同比增长 38%。2020年双十一电商购物节有超70%的个护美妆商品在预售阶段售出,商家可考虑在2021年双十一期间重点布局预售期。
According to data, in August 2021, the GMV of skin care and cosmetics on Ali's platform was 19.91 billion yuan, down 5.0% year-on-year, of which skin care GMV was 14 billion yuan, down 0.8% year-on-year, and cosmetics GMV was 5.92 billion yuan, down 13.6% year-on-year . On the Double Eleven e-commerce shopping festival, the average growth rate in the past five years has been 32.5%, and the shopping atmosphere is active. On the Double Eleven e-commerce shopping festival in 2020, the total sales of personal care and beauty products in the whole network is 90.9 billion yuan, a year-on-year increase of 43%. Among them, skin care sales reached 75.5 billion yuan, a year-on-year increase of 45%; beauty cosmetics sales were 15.4 billion yuan, a year-on-year increase of 38%. In 2020 Double Eleven e-commerce shopping festival, more than 70% of personal care and beauty products are sold in the pre-sale stage. Merchants may consider focusing on the pre-sale period during the 2021 Double Eleven period. -
艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告
本报告研究涉及企业/品牌/案例:华韩整形,瑞丽医美,美莱整形,医思健康
数据显示,2016—2020年中国医美行业市场规模五年平均增长率为12.8%,与此同时,中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下,预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等,民众对整形美容的观念正在向积极态度转变,在整个行业扩张的过程中,轻医美的受众面广、门槛低、复购率高,更有可能提升市场整体渗透率,成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry. -
艾媒咨询|2021-2022年中国医美器械产业运行及投资决策分析报告
本报告研究涉及企业/品牌/案例:科医人,复星医药,奇致激光,半岛医疗
伴随着医美市场规模的持续扩大,中国医美器械行业发展前景可期。数据显示,预计2021年中国医美器械市场规模将超过500亿元,同比增长27.8%。从细分赛道来看,近年来,微创和无创已逐渐成为医疗美容的趋势,这就推动了以激光、超声波等能量源为代表的光电类医美器械的发展。从市场格局来看,中国正规医美机构设备的市场份额80%是进口品牌,且中高端市场被飞顿、塞诺龙等海外龙头企业占领。为了改变这一局面,国家及地方先后出台政策鼓励本土医美器械品牌的发展,同时,国有品牌也通过加大自主研发投入和投资并购来扩大市场份额,未来随着下游扩张、需求渗透、技术更新等因素有望加速进口替代。
With the continuous expansion of the medical beauty market, the development prospect of the medical beauty equipment industry in China is promising. According to the data, it is estimated that in 2021, the market size of medical devices in China will exceed 50 billion yuan, with a year-on-year growth of 27.8%. From the perspective of subdivision, in recent years, minimally invasive and non-invasive have gradually become the trend of medical beauty, which promotes the development of photoelectric medical beauty devices represented by laser, ultrasonic and other energy sources. From the perspective of market structure, 80% of the market share of China's regular medical and beauty institutions' equipment is imported brands, and the medium and high-end market is occupied by overseas leading enterprises such as feton and sinolon. In order to change this situation, the state and local governments have successively issued policies to encourage the development of local medical and beauty equipment brands. At the same time, the state-owned brands also expand their market share by increasing independent R & D investment and investment in M & A. in the future, with the downstream expansion, demand penetration, technology update and other factors, it is expected to accelerate the import substitution.
- 1
- 2
- 3
- 4
- 5
- 6
- 19